Stock listing
Cannabis Bioscience International Holdings, Inc.
Selected listing: CBIH · OTC · USD · US
Cannabis Bioscience International Holdings, Inc. (OTC:CBIH), Commercial Services. Latest release Jul 20, 2026: CBIH Unveils Cannabinoid-Based Intranasal…
- Ticker
- OTC:CBIH
- Asset type
- Stock
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- OTC
- Currency
- USD
About Cannabis Bioscience International Holdings, Inc.
Cannabis Bioscience International Holdings, Inc. (CBIH) is a public company operating in the American market. The company is committed to advancing its position within this growing industry.
Latest news from Cannabis Bioscience International Holdings, Inc.
CBIH Unveils Cannabinoid-Based Intranasal Platform for Alzheimer's Research
July 20, 2026
Years of Preparation. One Regulatory Approval. Commercial Launch Begins: CBIH Receives Texas License for Consumable Hemp Products
July 15, 2026
CBIH Announces Recognition Initiative Funded Through CEO's Personal Share Holdings
July 6, 2026
Cannabis Bioscience International Holdings Opens New Revenue Pathway with First VitaCookies Licensing Agreement
June 22, 2026
CBIH Announces Patent-Related Scientific Framework for PTSD-Focused Cannabinoid and Psilocybin Research
June 15, 2026
Research Cannabis Bioscience International Holdings, Inc.
Cannabis Bioscience International Holdings, Inc. company profile
View the public company page for Cannabis Bioscience International Holdings, Inc. on 6ix.
Cannabis Bioscience International Holdings, Inc. news
Read company news and market updates connected to Cannabis Bioscience International Holdings, Inc..
Cannabis Bioscience International Holdings, Inc. investor events
Find investor webinars, events, and replay context for Cannabis Bioscience International Holdings, Inc..